A1LN34:BVMF
Alnylam Pharmaceuticals Inc Bdr
R$63.06
0.00%
(0.00) 1D
Sep 18, 12:21:21 PM GMT-3 · BRL
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for A1LN34...
Mkt. cap
32.69B
Avg. vol.
1.16K
Volume
0.00
52-wk high
R$132.40
52-wk low
R$50.25
Shares outstanding
133.81M
No. of employees
2K
Mkt. cap
32.69B
Avg. vol.
1.16K
Volume
0.00
52-wk high
R$132.40
52-wk low
R$50.25
Shares outstanding
133.81M
No. of employees
2K
News stories
From web sources and news partners
Investing.com
·
1 day ago
H.C. Wainwright reiterates Alnylam stock rating on trial outlook
Investing.com
·
1 day ago
H.C. Wainwright reiterates Alnylam stock rating on cardiovascular trial outlook
Profile
Alnylam Pharmaceuticals, Inc. is an American biopharmaceutical company focused on the discovery, development and commercialization of RNA interference therapeutics for genetically defined diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts. In 2016, Forbes included the company on its "100 Most Innovative Growth Companies" list. Wikipedia
About Alnylam Pharmaceuticals Inc Bdr